Dr. Matthew Vance Diltz, MD

Dr. Diltz practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Diltz's NPI, 1447456579, was assigned on June 25, 2007. Dr. Diltz graduated from Tulane School of Medicine in 2003. Dr. Diltz's California license number on file is A83315.

Dr. Diltz's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Diltz also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Diltz's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. The medical group on file is Desert Orthopedic Center. Dmand AI also links Dr. Diltz to 1 more breast imaging center, 1 clinical lab, 1 dialysis center and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diltz practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Diltz's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Diltz is board certified in orthopaedic sports medicine by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Diltz's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists arthritis and joint pain among the conditions Dr. Diltz treats.

CMS data shows 461 Medicare services from Dr. Diltz across 9 procedure codes in 2024, for 261 Medicare patients. Medicare paid $43,904 for them.

CMS counts 261 Medicare patients who saw Dr. Diltz in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have arthritis, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Diltz's median patient age at 53, with 52% women.

In 2024, Dr. Diltz wrote 90 Medicare Part D claims for 50 patients. 100% of them were for generic drugs. CMS names the drug for 54 of them, across 1 drug with 11 or more claims each, at $1,502 in total drug cost. In 2023, CMS named 75 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Diltz for performance year 2024, reported as part of a group. Dr. Diltz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of lower limb (leg) arthroscopy (minimally invasive joint repair) by Dr. Diltz, more than 99% of the clinicians it reports for that procedure.

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Diltz. Dr. Diltz's most frequent co-authors are Michael Fitzpatrick, MD, Robert Carlyle Grumet, MD and Ranjan Gupta, MD.

Dmand AI links Dr. Diltz to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Fractures, Stress and Hip Dislocation.

CMS Open Payments shows 90 general payments to Dr. Diltz from 13 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 37% of the total. Arthrex, Inc. paid the most, $6,173.

Dmand AI lists 1 award for Dr. Diltz, most recently CMS Stage 1 EHR in 2013.

Dr. Diltz graduated from Tulane School of Medicine in 2003.

Dr. Diltz is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.